, 95% CI 137 to 278, P < 0.01). Work histories of the copper cadmium alloy workers were combined with independent assessments of cadmium exposures over time to develop individual estimates of cumulative exposure to cadmium; this being a time dependent variable. Poisson regression was used to investigate risks of lung cancer and risks of chronic non-malignant diseases of the respiratory system in relation to three levels of cumulative cadmium exposure (< 1600, 1600-4799, > 4800 #g.m-3.y). After adjustment for age, year of starting alloy work, factory, and time from starting alloy work, there was a significant positive trend (P < 0.01) between cumulative exposure to cadmium and risks of mortality from chronic non-malignant diseases of the respiratory system. Relative to a risk of unity for the lowest exposure category, risks were 4 54 (95% CI 1*96 to 10.51) for the middle exposure category and 4-74 (95% CI 1*81 to 12-43) for the highest exposure category. There was a non-significant negative trend between cumulative cadmium exposure and risks of mortality from lung cancer. Relative to a risk of unity for the lowest exposure category, risks were 0 85 (95% CI 0-27 to 2.68) for the middle exposure category and 0-81 (95% CI 0-18 to 3.73) for the highest exposure category. Similar findings were obtained when adjustment was made for age only. Conclusions-The findings are consistent with the hypothesis that exposure to cadmium oxide fume increases risks of mortality from chronic non-malignant diseases of the respiratory system. The findings do not support the hypothesis that exposure to cadmium oxide fume increases risks of mortality for lung cancer. (Occup Environ Med 1995;52:804-812) 
tem. Methods-The mortality experience of 347 copper cadmium alloy workers, 624 workers employed in the vicinity of copper cadmium alloy work (vicinity workers), and 521 iron and brass foundry workers (all men) was investigated for the period 1946-92. All subjects were first employed in these types of work in the period 1922-78 and for a minimum period of one year at one of two participating factories. Two analytical approaches were used, indirect standardisation and Poisson regression. Results-Compared with the general population of England and Wales, mortality from lung cancer among copper cadmium alloy workers was close to expectation (observed deaths 18, expected deaths 17-8, standardized mortality ratio (SMR) 101, 95% confidence interval (95% CI) 60 to 159). A significant excess was shown for lung cancer among vicinity workers but not among iron and brass foundry workers (vicinity workers: observed 55, expected 34.3, SMR 160, 95% CI 121 to 209, P < 0-01; iron and brass foundry workers: observed 19, expected 17-8, SMR 107, 95% CI 64 to 167). Increased SMRs for non-malignant diseases of the respiratory system were shown for each of the three groups (alloy workers: observed 54, expected 23 5, SMR 230, 95% CI 172 to 300, P < 0*001; vicinity workers: observed 71, expected 43 0, SMR 165, 95% CI 129 to 208, P < 0*001; iron and brass foundry workers: observed 34, expected 17*1, SMR 199, 95% CI 137 to 278, P < 0.01). Work histories of the copper cadmium alloy workers were combined with independent assessments of cadmium exposures over time to develop individual estimates of cumulative exposure to cadmium; this being a time dependent variable. Poisson regression was used to investigate risks of lung cancer and risks of chronic non-malignant diseases of the respiratory system in relation to three levels of cumulative cadmium exposure (< 1600, 1600-4799, > 4800 #g.m-3.y). After adjustment for age, year of starting alloy work, factory, and time from starting alloy work, there was a significant positive trend (P < 0.01) between cumulative exposure to cadmium and risks of mortality from chronic non-malignant diseases of the respiratory system. Relative to a risk of unity for the lowest exposure category, risks were 4 54 (95% CI 1*96 to 10.51) for the middle exposure category and 4-74 (95% CI 1*81 to 12-43) for the highest exposure category. There was a non-significant negative trend between cumulative cadmium exposure and risks of mortality from lung cancer. Relative to a risk of unity for the lowest exposure category, risks were 0 85 (95% CI 0-27 to 2.68) for the middle exposure category and 0-81 (95% CI 0-18 to 3.73) for the highest exposure category. Similar findings were obtained when adjustment was made for age only. Conclusions-The findings are consistent with the hypothesis that exposure to cadmium oxide fume increases risks of mortality from chronic non-malignant diseases of the respiratory system. The findings do not support the hypothesis that exposure to cadmium oxide fume increases risks of mortality for lung cancer.
(Occup Environ Med 1995;52:804-812) Keywords: cadmium; lung cancer; respiratory diseases In 1953, a health survey of copper cadmium alloy workers from two factories (A and B) was carried out by Bonnell under the auspices of the Medical Research Council (MRC); findings relating to emphysema and proteinuria were reported in 1955.1 Of the 100 alloy workers examined, nine had emphysema and proteinuria, three had emphysema without proteinuria, and seven had proteinuria without emphysema. One hundred and four employees who had never had any work contact with copper cadmium alloy had been examined as a control group; only one case of proteinuria and one case of emphysema were diagnosed. A further group of 151 vicinity workers from factory B were examined. Vicinity workers, although employed in a workshop in which copper cadmium alloys were being made, were employed in the refining of copper and the manufacture of arsenical copper, phosphor bronze, and other copper alloys. Bonnell' reported "there were no cases in this group in whom the findings were consistent with the diagnosis of chronic cadmium poisoning." Chronic cadmium poisoning referred to proteinuria or emphysema induced by cadmium. In 1957, a follow up study produced diagnoses of proteinuria or emphysema in a further 24 men from the original group of 100 workers of copper cadmium alloy. 2 Holden published two short reports, which included information on the mortality of men employed for at least 12 months as copper cadmium alloy workers at either of the two factories; follow up was to the end of 1979.34 A more detailed analysis has now been carried out that includes the analysis of deaths occurring in a further 13 years of follow up. Particular emphasis is given to findings for lung cancer because of the recent evaluation by an international agency for research on cancer (IARC) Working Group that there was sufficient evidence in humans for the carcinogenicity of cadmium and cadmium compounds.5 (This evaluation seemed to rely heavily on the significant relations between risks of lung cancer and estimated cumulative exposure to cadmium reported by Thun Holden as a control group4; 16 members of Holden's original control group have now been excluded because they started employment in the foundry before 1922. The study populations had been abstracted by Holden from much larger sets of personnel records; the selected occupations represented only a small percentage of the total workforce at the two factories (personal communication, D O'Malley). Incomplete information on job histories were available from centralised personnel records at factory A; at factory B, starter and leaver books for the relevant departments were reviewed. (These books recorded, in chronological order, names of employees with dates of starting and leaving work in a given department.) Information obtained from these sources had been augmented by information obtained from company medical records, foremen, and long serving employees to identify those workers employed directly on the manufacture of copper cadmium alloys and those workers employed in the workshop that housed the copper cadmium process but who were never employed directly on the manufacture of copper cadmium alloys (vicinity workers). The final survey cards included information on job titles and dates carried out, dates of starting work on copper cadmium alloy and duration of alloy work.
Survey cards for all members of the cohort had been sent to the Office of Population Censuses and Surveys (OPCS);34 the OPCS continues to supply the principal investigator with copies of death certificates coded to the 8th revision of the international classification of disease (ICD-8) for those members of the study cohort who are dead together with embarkation details for those who have left the country. The study records have passed through several hands since the early reports3 4 and for the purpose of this analysis all relevant information held by OPCS was double checked with the vital status as recorded in the study computer file. A few errors were identified in the computer file and these were corrected. Table 1 shows the vital status of the study population on the closing date of the study, 31 December 1992. Vital status was unknown for only 1-7% of the total cohort although tracing was not as successful for alloy workers from factory A (6-5% untraced). It was not possible to obtain a copy of the death certificate for three of the deaths; these deaths appear only in tables of mortality from all causes. 
ESTIMATION OF CUMULATIVE CADMIUM EXPOSURES
As part of a study into inhalation of cadmium fume and emphysema among copper cadmium alloy workers at factory B, Davison et al reviewed 933 measurements of airborne cadmium made between 1951 and 1983 (697 with static samplers and 236 with personal samplers).9 Cadmium exposures were estimated "by consideration of all available measurements, changes in production techniques, ventilation, and levels of production and from discussions with the occupational health physician, industrial hygienist, the management, and the work force." Table 2 shows the final exposure assessments, which have been used to estimate individual cumulative exposures to cadmium as a time dependent variable. The cumulative exposure for each man who worked with copper cadmium alloy was calculated as the sum of the estimated exposures to cadmium during each year (or proportion, if part of a year) worked with copper cadmium alloy in the period 1922-80, expressed in pg.m-3.y. The exposure matrix relating to factory B (table 2) was also used to estimate cumulative exposures to cadmium for the alloy workers from factory A. Similar estimates were not available for vicinity workers, but static sampling results reported by King in 1955 are consistent with vicinity workers having about 10% of the cadmium exposures received by alloy workers (alloy section: mean exposure to cadmium 69 6 pug.m-3, n = 25; vicinity workers: mean cadmium exposures 6 16 pug.m-, n = 26).
EXTERNAL STANDARD
The mortality experience of this cohort was compared with that which might have been expected to occur if mortalities for the general population of England and Wales had been operating on the study cohort, with due regard to the composition of the study cohort by age (five-year age groups), sex (men only), and calendar year (five-year calendar periods).
Expectations based on person-years at risk were calculated with the PERSONYEARS computer program. The use of these values would have placed a relatively small percentage (8%) of observed deaths in the highest dose category so the higher of the two cut off values was reduced to 4800 ,ug.m-3.y (1753-2 mg.m-3.days). Analyses were also carried out with exposures lagged by 10 years-that is, exposures were assumed to have no effect until 10 years had elapsed. This procedure was accomplished by adding 10 years to the dates of transition from one exposure category to another. (Thus a worker who accumulated 1600 ,ug.m-3.y of cadmium exposure on 10 January 1951, would not accumulate this amount of lagged exposure until 10 January 1961.)
The EPICURE" computer program was used to provide both person-years at risk and numbers of deaths for causes of interest for all combinations of all levels of the above variables and to carry out statistical modelling by means of Poisson regression.'4 The purpose of the modelling was to establish whether the mortality experienced by the study cohort, and in particular the mortality experienced by the different cumulative exposure groups, could be described easily in terms of variables such as age and factory (covariates), or whether the inclusion of cumulative exposure to cadmium made a significant contribution to the ability of the overall model to describe the data. The significance of this contribution was assessed by the likelihood ratio test that compared deviance and degrees of freedom with and without inclusion of the cumulative cadmium exposure variable. Also, the significance of any trend in risk across the three exposure categories was assessed by repeating the analysis while treating cumulative exposure as a continuous variable coded 1, 2, or 3 for the three levels of exposure. Table 3 shows observed and expected numbers of deaths both for cancer by site and for broad groupings of non-cancers; results relate to Table 4 shows observed and expected numbers of deaths from lung cancer and nonmalignant diseases of the respiratory system by successive 10-year periods from first employment in the selected occupations; results are shown for copper cadmium alloy workers, vicinity workers, and brass and iron foundry workers. For lung cancer, a significant overall excess is shown for vicinity workers only. There are notable excesses in later periods of follow up, 20-39 years from starting local work. For non-malignant diseases of the respiratory system, significant overall excesses are shown for all three sub-cohorts. For earlier (< 20 years) and later (a 20 years) periods of follow up the SMRs were similar. Table 5 shows observed and expected numbers of deaths for all causes, lung cancer, nonmalignant diseases of the respiratory system and a large remainder category (all causes other than lung cancer and non-malignant dis- At the outset of this updated analysis, cancer of the lung (ICD-8 162-163) and chronic nonmalignant diseases of the respiratory system (ICD-8 490-519) were selected for further study. Cases were selected as those deaths for which any part of the death certificate (la, lb, 1 c, or II) would be coded to the above categories. Occupational exposure to cadmium was not expected to have a discernible influence on many causes of death. Consequently, mortality from all causes excluding lung cancer, nonmalignant chronic diseases of the respiratory system, and nephritis and nephrosis was also studied to assess the usefulness of the explanatory variables used in the statistical models. Table 7 provides relative risks (12 separate analyses) by levels of estimated cumulative exposures to cadmium (three levels: < 1600, 1600-4799, > 4800 ,ug.m-3.y) and based solely on the experience of the 347 copper cadmium alloy workers. 10 years. The inclusion of the variable cumulative exposure to cadmium made a highly significant improvement to the models for chronic nonmalignant diseases of the respiratory system; there were notably increased relative risks for this cause of death. The inclusion of the variable cumulative exposure to cadmium did not approach a significant improvement to the models for lung cancer; relative risks for this cause of death were close to (or below) unity.
Results

EXTERNAL STANDARD
Findings were not materially changed when the analysis was restricted to copper cadmium alloy workers from factory B. For example, the corresponding relative risks for the point estimates of 0 50 and 0-46 (table 7) for cancer of the lung were 1-34 (95% CI 0-44 to 4 .05) and 0-54 (95% CI 0.12 to 2 56). Corresponding relative risks for the point estimates of 3-46 and 3-32 shown for chronic nonmalignant diseases of the respiratory system were 5-47 (95% CI 2-11 to 14-19) and 3-19 (95% CI 1-06 to 9.61). When the analysis was restricted to copper cadmium alloy workers from factory A, corresponding relative risks for chronic non-malignant diseases of the respiratory system were 3 00 (95% CI 0.68 to [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] and 4 30 (95% CI 0-99 to 18-66). Findings were not obtained for cancer of the lung because there were only three deaths available for analysis.
It was possible to gain an independent The unusually low SMR for lung cancer among copper cadmium alloy workers from factory A was unexpected and possible reasons for this deficit were examined in some detail. The possibility of a major artifact (such as a group of lung cancer cases being inadvertently excluded from the study) was investigated. Such an exclusion could not have taken place after the cohort was traced by the OPCS because all data supplied by the OPCS in the lifetime of the study have been checked with the current computer files. It does not seem to have taken place at the time the cohort was defined-for example, if records for lung cancer cases known to the company had been filed separately from the source data used for this study-because the relevant SMR was low both for the period after the date of data collection (1981-92) and for the earlier period. Moreover, in 1980, health concerns for workers exposed to cadmium centred on cancer of the prostate, renal damage, and non-malignant diseases of the respiratory system; no survey was in progress at factory A on the topic of lung cancer. The findings for mortality among the participants of the 1953 MRC survey also add weight to the view that the deficit is not the result of an artifact in data collection, because data for the MRC survey were collected more than 20 years before this study was initiated. Some of the deficit may be due to regional differences; factory A was situated in a rural setting whereas factory B was in an urban setting. The lifestyles of alloy workers from the two factories may well have been similar; findings for all other causes of death combined would support this view. Many SMRs were calculated; it is not particularly surprising, therefore, that one of them should describe a significant deficit. It was not possible to assess the role of cigarette smoking in this deficit.
It was also important to gain some independent evidence of whether the individual cumulative estimates of exposure to cadmium used in the Poisson regression analyses provided reliable estimates of true exposures. Some supporting evidence was provided by the comparison of cumulative exposure estimates to cadmium with in vivo measurements of cadmium in liver; liver cadmium concentration has been found to be "proportional to duration and intensity of cadmium exposure in workers without as well as with renal dysfunction." '5 Further reassurance was provided by the positive Poisson regression findings for chronic non-malignant diseases of the respiratory system. These findings were not unexpected given what is already known about emphysema in copper cadmium alloy workers from these factories. 1-4 9 These data have limitations. Data on smoking histories were not available, although there is no reason to think that they would be correlated with the employment histories analysed in this study. More importantly, perhaps, quantitative data on occupational exposures other than cadmium were also not available. The subcohort of iron and brass foundry workers had been referred to by Holden4 as a control group, on the grounds that such employees were not exposed to cadmium but probably had similar social characteristics. They were working, however, in an extremely dirty environment and were exposed to considerable amounts of other chemicals, including polycylic aromatic hydrocarbons. It is these other exposures that were probably responsible, at least in part, for the increased SMRs for nonmalignant diseases of the respiratory system found in this group of workers. Likewise, the vicinity workers were exposed to a different mixture of chemicals and this mixture included arsenic. Arsenic exposure may be responsible, at least in part, for the increased SMRs obtained for lung cancer in this group of workers.'6 Exposure to cadmium would seem an unlikely explanation given that Bonnell' found "no cases in this group in whom the findings were consistent with the diagnosis of chronic cadmium poisoning" and given that King found relatively low levels of cadmium oxide fume in those parts of the workshop distant from the cadmium operations.'0 Arsenic exposure may also be responsible, at least in part, for the increased SMR found for copper cadmium alloy workers from factory B. These workers could have been exposed to arsenic in the general workshop environment or from unrecorded job rotations in the workshop. It is not inconceivable that a common exposure (which by definition could not be cadmium) was responsible for the similarly increased SMRs found for non-malignant diseases of the respiratory system among the copper cadmium alloy workers, the vicinity workers, and the iron and brass foundry workers, even though there was a positive association between risks of mortality and estimated cumulative exposure to cadmium among the copper cadmium alloy workers.
The study is also limited in that an independent historical assessment of cadmium exposures was only available for factory B. Its use for the copper cadmium alloy workers at factory A must have led to some errors in individual annual exposure estimates; misclassification relating to placement in one or more of the three levels of cumulative exposure used in the Poisson regression analysis, however, was probably modest given that processes were broadly similar and that improvements were made over time at both factories. Because the classification of work histories involved the help of former employees, it follows that the subcohorts could not now be accurately reabstracted from factory records. This is an unattractive but unavoidable feature of this study. Finally, if non-malignant diseases of the respiratory system and lung cancer are, in fact, long term sequelae of exposure to cadmium oxide fume, then the toll of mortality from nonmalignant disease may have acted as a cause of death competing with the lung cancer mortality in this study. Even taken together, however, the above limitations do not explain why the findings for lung cancer were so different from those for non-malignant diseases of the respiratory system.
In conclusion, the copper cadmium alloy workers studied in this cohort had excess risks of non-malignant diseases of the respiratory system rather than excess risks of lung cancer. Findings in relation to estimated cumulative exposures to cadmium were consistent with the hypothesis that exposure to cadmium oxide fume increases risks of mortality for chronic non-malignant diseases of the respiratory system.
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